Margreet Kerkmeer

  • Citations Per Year
Learn More
AIMS To evaluate whether rivastigmine, an achetylcholinesterase inhibitor (AChEl), may be effective in restoring memory in Wernicke-Korsakoff's syndrome (WKS). METHODS Five patients treated with rivastigmine for a period of 6 months were compared with five matched control patients, who received 6 months' conventional treatment, but without rivastigmine.(More)
The aim of the study was to evaluate the effect of residual concentrations of two contact lens care solutions (hydrogen peroxide and polyaminopropyl biguanide) on corneal barrier function in vivo. The barrier function was determined by fluorophotometric measurement of corneal epithelial permeability in 30 contact lens wearing healthy subjects after 1(More)
Aims: To evaluate whether rivastigmine, an achetylcholinesterase inhibitor (AChEl), may be effective in restoring memory in Wernicke-Korsakoff’s syndrome (WKS). Methods: Five patients treated with rivastigmine for a period of 6 months were compared with five matched control patients, who received 6 months’ conventional treatment, but without rivastigmine.(More)
  • 1